WuXi Vaccines, a leading contract development and manufacturing organisation (CDMO) focused on vaccine discovery, develo...
Univercells, a Belgian biotechnology company dedicated to ensuring that everyone has access to biologics everywhere in t...
South Korea-based ST Pharm has successfully marked the completion of its groundbreaking ceremony, signaling a significan...
South Korea-based Samsung Biologics has announced a new agreement with Bristol Myers Squibb (BMS) for large-scale manufa...
US-based National Resilience, Inc., a technology-focused biomanufacturing company dedicated to broadening access to comp...
The PDA Pharmaceutical Manufacturing & Quality Conference was held in Singapore on 15 and 16 August 2023. To achieve...
US-based Arcturus Therapeutics Holdings Inc., has announced that ARCALIS Co., its manufacturing joint venture in Japan t...
US-based ABVC BioPharma has received approval from the Science Park Administration in Taiwan to establish a pilot Good M...
Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, has announced an agreement to a...
The upcoming PDA Pharmaceutical Manufacturing & Quality Conference is schedule for 15-16 August 2023 in Singapore to...
On 11 July, 2023, Avantor, Inc., a leading global provider of life sciences and advanced technology solutions, officiall...
Merck, a leading science and technology company, is expanding production capacity for highly-purified reagents at its si...
GC Biopharma, a South Korean biopharmaceutical company, has successfully obtained final approval from the Indonesian Min...
China-headquartered WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRD...
Japan-based Chugai Pharmaceutical has announced its decision to construct a new bio active pharmaceutical ingredients (A...
US-based science and technology company, Merck has signed a non-binding Memorandum of Understanding (MoU) with the Minis...
MD Logistics, LLC, a group company of Japan-based Nippon Express Holdings, has opened Garner 2000 Pharmaceutical Lo...
Takeda Pharmaceutical will invest approximately 100 billion yen (¥) to build a new manufacturing facility for plasma...
